These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 36206621)

  • 1. Systemic inflammation after spinal cord injury: A review of biological evidence, related health risks, and potential therapies.
    Bigford GE; Garshick E
    Curr Opin Pharmacol; 2022 Dec; 67():102303. PubMed ID: 36206621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.
    Sun X; Jones ZB; Chen XM; Zhou L; So KF; Ren Y
    J Neuroinflammation; 2016 Oct; 13(1):260. PubMed ID: 27716334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response following traumatic spinal cord injury: Pathophysiology and therapies.
    Sterner RC; Sterner RM
    Front Immunol; 2022; 13():1084101. PubMed ID: 36685598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives.
    Chio JCT; Xu KJ; Popovich P; David S; Fehlings MG
    Exp Neurol; 2021 Jul; 341():113704. PubMed ID: 33745920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the vagus nerve and the inflammatory reflex for therapeutic benefit in chronic spinal cord injury.
    Bloom O; Tracey KJ; Pavlov VA
    Curr Opin Neurol; 2022 Apr; 35(2):249-257. PubMed ID: 35102123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy strategies for spinal cord injury.
    Wang YT; Lu XM; Chen KT; Shu YH; Qiu CH
    Curr Pharm Biotechnol; 2015; 16(6):492-505. PubMed ID: 25860061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic obesity and systemic inflammation following spinal cord injury: A review.
    Farkas GJ; Gater DR
    J Spinal Cord Med; 2018 Jul; 41(4):378-387. PubMed ID: 28758554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury.
    Kabu S; Gao Y; Kwon BK; Labhasetwar V
    J Control Release; 2015 Dec; 219():141-154. PubMed ID: 26343846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities.
    Ortega MA; Fraile-Martinez O; García-Montero C; Haro S; Álvarez-Mon MÁ; De Leon-Oliva D; Gomez-Lahoz AM; Monserrat J; Atienza-Pérez M; Díaz D; Lopez-Dolado E; Álvarez-Mon M
    Mil Med Res; 2023 Jun; 10(1):26. PubMed ID: 37291666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation: A Target for Treatment in Spinal Cord Injury.
    Freyermuth-Trujillo X; Segura-Uribe JJ; Salgado-Ceballos H; Orozco-Barrios CE; Coyoy-Salgado A
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Therapeutic Hypothermia After Traumatic Spinal Cord Injury--A Systematic Review.
    Alkabie S; Boileau AJ
    World Neurosurg; 2016 Feb; 86():432-49. PubMed ID: 26433095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord injury causes chronic liver pathology in rats.
    Sauerbeck AD; Laws JL; Bandaru VV; Popovich PG; Haughey NJ; McTigue DM
    J Neurotrauma; 2015 Feb; 32(3):159-69. PubMed ID: 25036371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A center's experience: pulmonary function in spinal cord injury.
    Schilero GJ; Radulovic M; Wecht JM; Spungen AM; Bauman WA; Lesser M
    Lung; 2014 Jun; 192(3):339-46. PubMed ID: 24723067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammatory response syndrome in patients with spinal cord injury: does its presence at admission affect patient outcomes? Clinical article.
    Kesani AK; Urquhart JC; Bedard N; Leelapattana P; Siddiqi F; Gurr KR; Bailey CS
    J Neurosurg Spine; 2014 Aug; 21(2):296-302. PubMed ID: 24836657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical spinal cord injury-induced neuropathic pain in male mice is associated with a persistent pro-inflammatory macrophage/microglial response in the superficial dorsal horn.
    Brown EV; Falnikar A; Heinsinger N; Cheng L; Andrews CE; DeMarco M; Lepore AC
    Exp Neurol; 2021 Sep; 343():113757. PubMed ID: 33991526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pre-hospital epidemiology and management of spinal cord injuries in New South Wales: 2004-2008.
    Middleton PM; Davies SR; Anand S; Reinten-Reynolds T; Marial O; Middleton JW
    Injury; 2012 Apr; 43(4):480-5. PubMed ID: 22244002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Cardiovascular Concerns after Spinal Cord Injury: Mechanisms, Maladaptations, and Management.
    Phillips AA; Krassioukov AV
    J Neurotrauma; 2015 Dec; 32(24):1927-42. PubMed ID: 25962761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury.
    Dyck S; Kataria H; Alizadeh A; Santhosh KT; Lang B; Silver J; Karimi-Abdolrezaee S
    J Neuroinflammation; 2018 Mar; 15(1):90. PubMed ID: 29558941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of timing in the treatment of spinal cord injury.
    Saghazadeh A; Rezaei N
    Biomed Pharmacother; 2017 Aug; 92():128-139. PubMed ID: 28535416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keeping promises: translating basic research into new spinal cord injury therapies.
    Kleitman N
    J Spinal Cord Med; 2004; 27(4):311-8. PubMed ID: 15484661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.